This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharmaceutical Compliance Congress (PCC) 2026
April 27-29, 2026
The Ritz-Carlton, Tysons Corner | McLean, VA

Jennifer Sanfilippo
General Counsel and Chief Compliance Officer at Melinta Therapeutics
Speaker

Profile

Jennifer Sanfilippo serves as General Counsel and Chief Compliance Officer at Melinta Therapeutics. Ms. Sanfilippo joined Melinta Therapeutics in 2018, after holding several leadership roles at The Medicines Company, where she was responsible for legal and compliance counseling for multiple business units guiding commercial, medical, market access, and regulatory activities.

Before The Medicines Company, Ms. Sanfilippo was an attorney at Porzio, a regional law firm specializing in the life sciences industry. Ms. Sanfilippo holds a B.A. in History, magna cum laude, from New York University and a J.D. from the Rutgers School of Law, where she was a member of the moot court board and managing editor of the Rutgers Law Review.

Jennifer Sanfilippo's Network

Agenda Sessions

  • QUICK FIRE USE CASE Successful Compliance Communication Strategies in Action

    2:15pm